Generics in North America
Summary
Generics in North America industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The North American generics market had total revenues of $120.7bn in 2019, representing a compound annual growth rate (CAGR) of 4% between 2015 and 2019.
- 麻豆原创 consumption volume increased with a CAGR of 1.2% between 2015 and 2019, to reach a total of 85.9 % in 2019.
- The huge size of the US market means that it made up over 90% of the value of the North American region in 2019
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in North America
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in North America
- Leading company profiles reveal details of key generics market players鈥� global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the North America generics market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the North America generics market by value in 2019?
- What will be the size of the North America generics market in 2024?
- What factors are affecting the strength of competition in the North America generics market?
- How has the market performed over the last five years?
- How large is North America鈥檚 generics market in relation to its regional counterparts?
Table of Contents
1 Executive Summary
1.1. 麻豆原创 value
1.2. 麻豆原创 value forecast
1.3. 麻豆原创 volume
1.4. 麻豆原创 volume forecast
1.5. Geography segmentation
1.6. 麻豆原创 rivalry
1.7. Competitive Landscape
2 麻豆原创 Overview
2.1. 麻豆原创 definition
2.2. 麻豆原创 analysis
3 麻豆原创 Data
3.1. 麻豆原创 value
3.2. 麻豆原创 volume
4 麻豆原创 Segmentation
4.1. Geography segmentation
5 麻豆原创 Outlook
5.1. 麻豆原创 value forecast
5.2. 麻豆原创 volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How has the outbreak of COVID-19 impacted leading players?
8 Company Profiles
8.1. Teva Pharmaceutical Industries Limited
8.2. Mylan N.V.
8.3. Pfizer Inc.
9 Appendix
9.1. Methodology
9.2. About 麻豆原创Line
List of Tables
List of Tables
Table 1: North America generics market value: $ billion, 2015-19
Table 2: North America generics market volume: % of total pharma, 2015-19
Table 3: North America generics market geography segmentation: $ billion, 2019
Table 4: North America generics market value forecast: $ billion, 2019-24
Table 5: North America generics market volume forecast: % of total pharma, 2019-24
Table 6: Teva Pharmaceutical Industries Limited: key facts
Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Limited: Key Employees
Table 9: Mylan N.V.: key facts
Table 10: Mylan N.V.: Annual Financial Ratios
Table 11: Mylan N.V.: Key Employees
Table 12: Pfizer Inc.: key facts
Table 13: Pfizer Inc.: Annual Financial Ratios
Table 14: Pfizer Inc.: Key Employees
Table 15: Pfizer Inc.: Key Employees Continued
List of Figures
List of Figures
Figure 1: North America generics market value: $ billion, 2015-19
Figure 2: North America generics market volume: % of total pharma, 2015-19
Figure 3: North America generics market geography segmentation: % share, by value, 2019
Figure 4: North America generics market value forecast: $ billion, 2019-24
Figure 5: North America generics market volume forecast: % of total pharma, 2019-24
Figure 6: Forces driving competition in the generics market in North America, 2019
Figure 7: Drivers of buyer power in the generics market in North America, 2019
Figure 8: Drivers of supplier power in the generics market in North America, 2019
Figure 9: Factors influencing the likelihood of new entrants in the generics market in North America, 2019
Figure 10: Factors influencing the threat of substitutes in the generics market in North America, 2019
Figure 11: Drivers of degree of rivalry in the generics market in North America, 2019
Teva Pharmaceutical Industries Limited
Mylan N.V.
Pfizer Inc.
Pfizer Inc.
听
听
*If Applicable.